XERS Free Cash Flow Growth
Xeris Biopharma Holdings Inc · Free Cash Flow Growth
XERS Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported430.06%period ending
XERS TTM Free Cash Flow YoY % (-127.85% → 430.06%)
Year-over-year change
High-resolution chart · PNG
XERS free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 430.0632% | |
| 272.1979% | |
| 173.0217% | |
| 128.9477% | |
| 58.0686% | |
| 38.4515% | |
| 25.0084% | |
| 54.1001% | |
| 47.2479% | |
| 45.2472% | |
| 51.1957% | |
| 37.3061% | |
| 37.4316% | |
| 32.542% | |
| -7.0327% | |
| -47.8197% | |
| -66.7891% | |
| -58.0165% | |
| -19.3797% | |
| 21.0923% | |
| 36.0424% | |
| 32.4763% | |
| 23.2502% | |
| -5.7683% | |
| -42.1296% | |
| -59.2423% | |
| -82.4794% | |
| -94.1121% | |
| -113.4832% | |
| -139.558% | |
| -127.8477% |